Selectively killing transformed cells through proteasome inhibition.
Grant
Steven
S
D018943:Anthracyclines / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D001897:Boronic Acids / Q000494:pharmacology; D000069286:Bortezomib; D002471:Cell Transformation, Neoplastic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D011480:Protease Inhibitors / Q000494:pharmacology; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D061988:Proteasome Inhibitors; D011719:Pyrazines / Q000494:pharmacology; D054875:Ubiquitination
D018943:Anthracyclines; D000970:Antineoplastic Agents; D001897:Boronic Acids; D011480:Protease Inhibitors; D061988:Proteasome Inhibitors; D011719:Pyrazines; C058288:PI 083; D000069286:Bortezomib; D046988:Proteasome Endopeptidase Complex